Summary:
We are conducting a 12-week multi-center study to assess the effectiveness of an investigational drug in comparison to a placebo for people with insomnia. The 12 week blinded study will be followed by a 40 week open study drug phase.
Qualified Participants Must:
• Be 18 years of age or older
•
Have primary insomnia that impacts daytime functioning
•
Have Body Mass Index less than 32
•
Have no history of sleep apnea, narcolepsy, or restless leg syndrome
Qualified Participants May Receive:
Study medications and study related physical exam at no cost. Qualified participants will receive a stipend to cover time and travel.